Skip to main content

Benkowitz Michael's Form 4 filing

United Therapeutics Corp (UTHR) · filed Jan 28, 2025

Accession no.
0001562180-25-000615
Filed
Jan 28, 2025
Trade date
Jan 27, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 12 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.71M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Benkowitz MichaelCIK 0001673232Officer (PRESIDENT AND COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 27, 2025Common StockMOption exerciseAcquired+7,500$111.00+$832,5007,500Indirect
Jan 27, 2025Common StockSSaleDisposed−4,147$369.54F3−$1,532,482.383,353Indirect
Jan 27, 2025Common StockSSaleDisposed−1,009$370.54F4−$373,874.862,344Indirect
Jan 27, 2025Common StockSSaleDisposed−544$371.52F5−$202,106.881,800Indirect
Jan 27, 2025Common StockSSaleDisposed−1,000$372.41F6−$372,410800Indirect
Jan 27, 2025Common StockSSaleDisposed−700$373.62F7−$261,534100Indirect
Jan 27, 2025Common StockSSaleDisposed−100$375.22−$37,5220Indirect
Jan 27, 2025Common StockMOption exerciseAcquired+2,500$111.00+$277,5002,500Indirect
Jan 27, 2025Common StockSSaleDisposed−1,395$369.70F9−$515,731.51,105Indirect
Jan 27, 2025Common StockSSaleDisposed−405$371.09F10−$150,291.45700Indirect
Jan 27, 2025Common StockSSaleDisposed−500$372.66F11−$186,330200Indirect
Jan 27, 2025Common StockSSaleDisposed−200$373.99−$74,7980Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 27, 2025Common StockMOption exerciseDisposed−7,500$0.00$037,179Indirect
Jan 27, 2025Common StockMOption exerciseDisposed−2,500$0.00$014,500Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

This transaction was executed in multiple trades at prices ranging from $369.08 to $370.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $370.09 to $371.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $371.09 to $372.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $372.09 to $372.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $373.16 to $373.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $369.49 to $370.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F10

This transaction was executed in multiple trades at prices ranging from $370.69 to $371.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F11

This transaction was executed in multiple trades at prices ranging from $372.21 to $373.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)